Voyager Therapeutics Inc (NASDAQ:VYGR)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in a research note issued to investors on Sunday, Market Beat Ratings reports. They currently have a $36.00 price objective on the stock. Wedbush’s price target would suggest a potential upside of 275.39% from the company’s current price. Several other […]
